Clinical Trial Update: Esmolol to Treat the Hemodynamic Effects of Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial investigating esmolol to treat hemodynamic effects of septic shock was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension
• Septic Shock
• Tachycardia

Drugs mentioned

• Esmolol (esmolol)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Septic Shock, Hypotension | Phase 2 | Status: TERMINATED | Results posted: 2021-06-28